Missouri vs Illinois Cannabis Laws

Missouri has rapidly become one of the most significant cannabis markets in the Midwest. Voters approved Amendment 3 in November 2022, legalizing recreational cannabis, and adult-use sales launched in February 2023. The state's medical program, established through Amendment 2 in 2018, had already built a robust infrastructure with over 200 licensed dispensaries and a large registered patient base.

The Missouri market has exceeded expectations, with annual sales quickly surpassing $1.5 billion. The state benefits from a population of over 6 million, the Kansas City and St. Louis metropolitan areas, and minimal competition from neighboring states (Kansas remains fully illegal, and Iowa and Nebraska have restrictive programs). Missouri's low 6% excise tax rate is among the most competitive in the nation, helping the legal market undercut illicit sources.

Major MSOs including Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, and Verano have built significant Missouri operations. Amendment 3 also includes provisions for automatic expungement of prior cannabis convictions and microbusiness licenses aimed at promoting equity and small business participation. Missouri is widely regarded as a top-ten US cannabis market by revenue.

Illinois made history in 2019 as the first state to legalize recreational cannabis through its legislature rather than a voter ballot initiative. The Cannabis Regulation and Tax Act took effect January 1, 2020, and first-day sales set national records. The state's medical program had been operational since 2013, providing an infrastructure foundation for the recreational rollout.

With annual sales exceeding $2 billion, Illinois ranks among the top cannabis markets in the nation. The state benefits from a large population of nearly 13 million, the Chicago metropolitan area's consumer base, and significant cross-border traffic from neighboring states where cannabis remains less accessible. Illinois uses a tiered tax system based on THC potency, with rates ranging from 7% on low-THC flower to 25% on high-potency concentrates.

Illinois is a priority market for nearly all major MSOs. Green Thumb Industries and Cresco Labs are both headquartered in Chicago, and the state hosts operations from Curaleaf, Trulieve, Verano, and TerrAscend. The social equity licensing program, which aimed to ensure communities harmed by the War on Drugs could participate in the industry, has faced implementation delays and legal challenges but remains a key component of the state's regulatory philosophy.